Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs... Show more
Industry PharmaceuticalsGeneric
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AAPW | 41.34 | 0.84 | +2.08% |
| Roundhill AAPL WeeklyPay ETF | |||
| ENDW | 35.27 | 0.14 | +0.40% |
| Cambria Endowment Style ETF | |||
| DPG | 13.91 | 0.01 | +0.07% |
| Duff & Phelps Utility and Infrastructure Fund | |||
| MPL | 15.95 | N/A | N/A |
| Defiance Daily Target 2X Long MP ETF | |||
| HGER | 36.14 | -0.32 | -0.88% |
| Harbor Commodity All-Weather StrategyETF | |||
A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with OCUL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then OCUL could also see price increases.
| Ticker / NAME | Correlation To AMLX | 1D Price Change % | ||
|---|---|---|---|---|
| AMLX | 100% | -1.46% | ||
| OCUL - AMLX | 46% Loosely correlated | -1.22% | ||
| LRMR - AMLX | 45% Loosely correlated | +1.82% | ||
| JAZZ - AMLX | 43% Loosely correlated | +2.21% | ||
| RGNX - AMLX | 43% Loosely correlated | -0.35% | ||
| IDYA - AMLX | 43% Loosely correlated | +0.37% | ||
More | ||||
| Ticker / NAME | Correlation To AMLX | 1D Price Change % |
|---|---|---|
| AMLX | 100% | -1.46% |
| Pharmaceuticals: Generic industry (84 stocks) | 1% Poorly correlated | -0.05% |
| Pharmaceuticals industry (155 stocks) | 0% Poorly correlated | -0.04% |
AMLX's Aroon Indicator triggered a bullish signal on September 01, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 205 similar instances where the Aroon Indicator showed a similar pattern. In 188 of the 205 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMLX advanced for three days, in 232 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The 10-day RSI Indicator for AMLX moved out of overbought territory on August 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 22 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMLX as a result. In 68 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for AMLX turned negative on September 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 36 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
AMLX broke above its upper Bollinger Band on August 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.728) is normal, around the industry mean (46.728). P/E Ratio (2.686) is within average values for comparable stocks, (93.360). AMLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.931). AMLX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (3.627) is also within normal values, averaging (176.516).
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.